v3.25.2
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Summary of Segment Information for Revenue, Significant Segment Expenses and Net Loss as Regularly Provided to the CODM

The following table presents segment information for revenue, significant segment expenses, and net loss, as regularly provided to the CODM, for the three and six months ended June 30, 2025 and 2024 (in thousands):

 

Three Months Ended

 

 

Six Months Ended

 

 

June 30,

 

 

June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Revenue

$

17

 

 

$

24

 

 

$

55

 

 

$

24

 

Less:

 

 

 

 

 

 

 

 

 

 

 

Cost of revenue

 

41

 

 

 

20

 

 

 

81

 

 

 

37

 

Payroll related expenses

 

3,992

 

 

 

3,257

 

 

 

7,892

 

 

 

6,635

 

Consulting and professional fees

 

2,042

 

 

 

1,479

 

 

 

3,875

 

 

 

3,332

 

Stock-based compensation expense

 

1,344

 

 

 

2,023

 

 

 

2,837

 

 

 

3,716

 

Equipment, lab supplies, and facility expenses

 

434

 

 

 

447

 

 

 

803

 

 

 

923

 

Clinical studies and outside processing

 

430

 

 

 

1,239

 

 

 

717

 

 

 

1,867

 

Depreciation and amortization(1)

 

208

 

 

 

208

 

 

 

395

 

 

 

421

 

Other segment items(2)

 

846

 

 

 

604

 

 

 

2,025

 

 

 

1,443

 

Loss from operations

 

(9,320

)

 

 

(9,253

)

 

 

(18,570

)

 

 

(18,350

)

Interest expense

 

(2

)

 

 

(8

)

 

 

(6

)

 

 

(17

)

Other income, net

 

1,276

 

 

 

958

 

 

 

2,343

 

 

 

1,967

 

Net loss

$

(8,046

)

 

$

(8,303

)

 

$

(16,233

)

 

$

(16,400

)

 

(1)
Certain amortization amounts are included within cost of revenue.
(2)
Other segment items consist primarily of insurance costs, IT services, travel expenses, marketing expenses, taxes, and other miscellaneous expenses.